Literature DB >> 10643907

Development of Wuchereria bancrofti in Culex quinquefasciatus that survived the exposure of sub-lethal dose of Bacillus sphaericus as larvae.

K Gunasekaran1, V Padmanaban, K Balaraman.   

Abstract

Development of Wuchereria bancrofti in Culex quinquefasciatus emerged from the larvae that survived the exposure of sub-lethal dose of Bacillus sphaericus was examined in the laboratory. Third instar larvae of Cx. quinquefasciatus were treated with B. sphaericus at a sub-lethal dose of 11.35 microg/250 ml. The female mosquitoes that emerged from the survived larvae were fed on microfilaraemic human blood and parasite development was monitored in the fed mosquitoes. Both treated and untreated mosquitoes could ingest microfilaria (mF) equally as there was no significant difference in mF density between them. But, density of developmental stages of the parasite in treated group was significantly lower. Since, there was no mortality of mosquitoes, the lower density of the developmental stages could be attributed to the loss of parasites in the treated mosquitoes. Consequently, the proportion of mosquitoes with infective larvae (L3) and number of L3 were also significantly lower in treated females. Delay in parasite development was also noticed in treated mosquitoes. The present study indicates that B. sphaericus, when applied at sub-lethal dose kills larvae, and in addition, inhibits development of the filarial parasite and consequently reduces L3 yield in adult mosquitoes that emerged from the survived larvae.

Entities:  

Mesh:

Year:  2000        PMID: 10643907     DOI: 10.1016/s0001-706x(99)00053-4

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  1 in total

1.  Bacillus sphaericus in the adults of Culex quinquefasciatus mosquitoes emerged from treated larvae and its effect on development of the filarial parasite, Wuchereria bancrofti.

Authors:  K P Paily; I Geetha; B A Kumar; K Balaraman
Journal:  Parasitol Res       Date:  2011-12-16       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.